Evidence map›Paper›PMID 31788990›Full record

ArticleAnnals of clinical and translational neurology2020

Severe white matter damage in SHANK3 deficiency: a human and translational study.

Sarah Jesse, Hans-Peter Müller, Michael Schoen, Harun Asoglu, Juergen Bockmann, Hans-Juergen Huppertz, Volker Rasche, Albert C Ludolph, Tobias M Boeckers, Jan Kassubek

Abstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Reduced brain volume and white matter alterations in Shank3-deficient rats.Autism research : official journal of the International Society for Autism Research · 2021
    Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah JesseDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0001-6235-8145
Hans-Peter MüllerDepartment of Neurology, Ulm University, Ulm, Germany.
Michael SchoenInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Harun AsogluInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Juergen BockmannInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.
Hans-Juergen HuppertzSwiss Epilepsy Clinic, Hospital Lengg, Zurich, Switzerland.ORCID 0000-0003-3856-9094
Volker RascheCore Facility Small Animal MRI, Ulm University, Ulm, Germany.ORCID 0000-0001-8844-3583
Albert C LudolphDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0002-5401-0904
Tobias M BoeckersInstitute for Anatomy and Cell Biology, Ulm University, Ulm, Germany.ORCID 0000-0002-1486-8535
Jan KassubekDepartment of Neurology, Ulm University, Ulm, Germany.ORCID 0000-0002-7106-9270

Funding

BIU2DFG A02DFG SFB1149the DZNEthe Else Kröner-Fresenius Stiftungthe Innovative Medicines Initiative (IMI) n777394Ulm University
6 · The paper itself

Abstract

objectiveHeterozygous SHANK3 mutations or partial deletions of the long arm of chromosome 22, also known as Phelan-McDermid syndrome, result in a syndromic form of the autism spectrum as well as in global developmental delay, intellectual disability, and several neuropsychiatric comorbidities. The exact pathophysiological mechanisms underlying the disease are still far from being deciphered but studies of SHANK3 models have contributed to the understanding of how the loss of the synaptic protein SHANK3 affects neuronal function. METHODS AND

resultsDiffusion tensor imaging-based and automatic volumetric brain mapping were performed in 12 SHANK3-deficient participants (mean age 19 ± 15 years) versus 14 age- and gender-matched controls (mean age 29 ± 5 years). Using whole brain-based spatial statistics, we observed a highly significant pattern of white matter alterations in participants with SHANK3 mutations with focus on the long association fiber tracts, particularly the uncinate tract and the inferior fronto-occipital fasciculus. In contrast, only subtle gray matter volumetric abnormalities were detectable. In a back-translational approach, we observed similar white matter alterations in heterozygous isoform-specific Shank3 knockout (KO) mice. Here, in the baseline data sets, the comparison of Shank3 heterozygous KO vs wildtype showed significant fractional anisotropy reduction of the long fiber tract systems in the KO model. The multiparametric Magnetic Resonance Imaging (MRI) analysis by DTI and volumetry demonstrated a pathology pattern with severe white matter alterations and only subtle gray matter changes in the animal model.

interpretationIn summary, these translational data provide strong evidence that the SHANK3-deficiency-associated pathomechanism presents predominantly with a white matter disease. Further studies should concentrate on the role of SHANK3 during early axonal pathfinding/wiring and in myelin formation.

Indexed as

AdolescentAdultAnimalsAutism Spectrum DisorderChildChild, PreschoolChromosome DeletionChromosome DisordersChromosomes, Human, Pair 22Diffusion Tensor ImagingDisease Models, AnimalFemaleGray MatterHumansMaleMice, Inbred C57BLMicrofilament ProteinsNerve Tissue ProteinsSHANK3 protein, humanShank3 protein, mouse

Identifiers

PMID31788990
PMCPMC6952316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.